Risk Mitigation in Breast Predictive Factor Testing

In this course, the risks to laboratories and pathologists inherent in biomarker testing are described along with a process to identify and mitigate the risks of testing.

Lecture Presenter
Elizabeth H. Hammond, MD, FCAP
Elizabeth H. Hammond, MD, FCAP
Consulting Pathologist, Intermountain Healthcare
Professor of Pathology, University of Utah School of Medicine

Dr. Elizabeth Hammond is a consulting pathologist with Intermountain Healthcare and professor of pathology and adjunct professor of internal medicine (cardiology) at the University of Utah School of Medicine. She is also a past member of Intermountain’s Board of Trustees. She was recently recognized and presented with two awards presented by the College of American Pathologists (CAP): 1) the CAP Pathology Advancement Award, of which she is the first recipient; and 2) the CAP Excellence in Education Award.

Objectives

After this presentation, participants will be able to:

Describe the categories of risks of biomarker testing for laboratories and give examples.
Define a process of identifying specific laboratory risks of biomarker testing and then defining interventions that will mitigate those risks for the laboratories.